Statistics for A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND)
Total visits
| views | |
|---|---|
| A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND) | 43 |
Total visits per month
| views | |
|---|---|
| December 2024 | 1 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| RESPOND_ArticleOphthalmicResearch_2017.pdf(legacy) | 186 |
| MAJOR RIBEIRO FARIA.pdf(legacy) | 1 |
| Dissertação Sília MLPO.pdf(legacy) | 1 |
| RESPOND_ArticleOphthalmicResearch_2017.pdf | 1 |
Top country views
| views | |
|---|---|
| United States | 19 |
| Portugal | 8 |
| China | 7 |
| France | 1 |
| United Kingdom | 1 |
| Hong Kong SAR China | 1 |
| Ireland | 1 |
| India | 1 |
| Mexico | 1 |
| New Zealand | 1 |